Simplex Trading’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,641
| Closed | -$281K | – | 10216 |
|
|
2025
Q3 | $281K | Buy |
+2,641
| New | +$276K | ﹤0.01% | 4544 |
|
|
2025
Q1 | – | Sell |
-8,601
| Closed | -$514K | – | 9791 |
|
|
2024
Q4 | $399K | Sell |
8,601
-23,629
| -73% | -$887K | ﹤0.01% | 3778 |
|
|
2024
Q3 | $927K | Buy |
32,230
+21,293
| +195% | +$524K | ﹤0.01% | 2986 |
|
|
2024
Q2 | $158K | Sell |
10,937
-16,759
| -61% | -$245K | ﹤0.01% | 4887 |
|
|
2024
Q1 | $445K | Sell |
27,696
-30,726
| -53% | -$531K | ﹤0.01% | 3965 |
|
|
2023
Q4 | $1.16M | Buy |
58,422
+54,568
| +1,416% | +$806K | ﹤0.01% | 2871 |
|
|
2023
Q3 | $62K | Sell |
3,854
-24,039
| -86% | -$463K | ﹤0.01% | 5609 |
|
|
2023
Q2 | $589K | Buy |
+27,893
| New | +$595K | ﹤0.01% | 3137 |
|
|
2023
Q1 | – | Sell |
-71,332
| Closed | -$1.54M | – | 10233 |
|
|
2022
Q4 | $1.86M | Buy |
+71,332
| New | +$950K | ﹤0.01% | 1933 |
|
|
2022
Q3 | – | Sell |
-7,866
| Closed | -$66.3K | – | 10972 |
|
|
2022
Q2 | $32K | Buy |
7,866
+2,114
| +37% | +$9.04K | ﹤0.01% | 7081 |
|
|
2022
Q1 | $28K | Buy |
5,752
+1,380
| +32% | +$8.03K | ﹤0.01% | 7868 |
|
|
2021
Q4 | $29K | Buy |
+4,372
| New | +$22.3K | ﹤0.01% | 7959 |
|
Other funds holding VRNA
Simplex Trading's VRNA Position: Q4 2025 in Review
Simplex Trading sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 2,641 shares — an estimated $281K sold.
Simplex Trading first reported a position in VRNA in Q4 2021 and held it in 12 quarters. The position peaked at $1.86M in Q4 2022. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Simplex Trading reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 2,641 Verona Pharma shares in Q4 2025, an estimated $281K.
- Simplex Trading first reported a position in Verona Pharma in Q4 2021 and held it in 12 quarters.
- Simplex Trading's Verona Pharma position peaked at $1.86M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.